Adaptive Biotechnologies Corporation
ADPT
$9.29
-$0.22-2.31%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 193.42M | 222.29M | 243.33M | 291.88M | 308.87M |
| Total Receivables | 45.08M | 43.03M | 42.11M | 36.81M | 43.12M |
| Inventory | 8.68M | 8.44M | 11.96M | 13.21M | 13.29M |
| Prepaid Expenses | 9.30M | 9.99M | 10.95M | 9.65M | 8.75M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 256.49M | 283.75M | 308.35M | 351.55M | 374.03M |
|
|
|||||
| Total Current Assets | 256.49M | 283.75M | 308.35M | 351.55M | 374.03M |
| Net Property, Plant & Equipment | 88.43M | 94.38M | 97.84M | 103.94M | 116.26M |
| Long-term Investments | 118.97M | 118.97M | 118.97M | 118.97M | 118.97M |
| Goodwill | 118.97M | 118.97M | 118.97M | 118.97M | 118.97M |
| Total Other Intangibles | 3.01M | 3.43M | 3.85M | 4.28M | 4.71M |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 4.60M | 5.18M | 5.63M | 6.13M | 6.35M |
| Total Assets | 510.85M | 539.38M | 558.51M | 584.87M | 620.32M |
|
|
|||||
| Total Accounts Payable | 6.36M | 7.27M | 7.35M | 9.87M | 12.17M |
| Total Accrued Expenses | 14.17M | 20.67M | 18.40M | 16.23M | 14.32M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 12.47M | 11.10M | 10.02M | 9.81M | 9.59M |
| Total Finance Division Other Current Liabilities | 54.81M | 59.02M | 51.86M | 52.23M | 46.87M |
| Total Other Current Liabilities | 54.81M | 59.02M | 51.86M | 52.23M | 46.87M |
| Total Current Liabilities | 87.81M | 98.05M | 87.63M | 88.13M | 82.95M |
|
|
|||||
| Total Current Liabilities | 87.81M | 98.05M | 87.63M | 88.13M | 82.95M |
| Long-Term Debt | 131.55M | 132.41M | 132.70M | 132.08M | 131.55M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 76.44M | 79.15M | 81.80M | 84.37M | 86.90M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 24.83M | 27.28M | 32.80M | 38.86M | 44.16M |
| Total Liabilities | 320.63M | 336.89M | 334.93M | 343.44M | 345.56M |
|
|
|||||
| Common Stock & APIC | 1.52B | 1.51B | 1.49B | 1.48B | 1.47B |
| Retained Earnings | -1.33B | -1.30B | -1.27B | -1.24B | -1.19B |
| Treasury Stock & Other | 134.00K | 166.00K | 497.00K | -182.00K | -106.00K |
| Total Common Equity | 190.42M | 202.71M | 223.77M | 241.60M | 274.91M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 190.42M | 202.71M | 223.77M | 241.60M | 274.91M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -202.00K | -224.00K | -199.00K | -173.00K | -147.00K |
| Total Equity | 190.22M | 202.49M | 223.57M | 241.43M | 274.77M |
|
|
|||||